Connect Sign In
ARUP Consult Provides New Resources on Multiple Sclerosis, Minimal Residual Disease, and Mumps Virus
ARUP Consult, a free source of expert guidance in laboratory testing, has released new and updated educational resources for multiple sclerosis, minimal residual disease, and mumps virus.
New ARUP Resource Simplifies Laboratory Testing Decisions for Clinicians Treating Multiple Sclerosis
A new ARUP Consult tool helps clarify the testing requirements for medication management when clinicians are treating patients with multiple sclerosis.
Laboratory-developed tests made up only about 4% of an academic health system’s total test orders in 2021, yet they played an important role in patient care, a new study shows.
ARUP Consult, a free source of expert guidance in laboratory testing, has updated educational resources for venous thromboembolism, cytomegalovirus, and hemoglobinopathies.
Routine monitoring of patients taking direct factor Xa inhibitors is not required, but the efficacy and safety of this treatment can be measured with ARUP’s newest test offerings.
ARUP CMOs are coauthors of a newly published JAMA Research Letter that summarizes how clinical labs are leading the way in eliminating inequality in healthcare.
Lauren Pearson, DO, MPH, has been appointed to serve as the first chief medical officer of ARUP at University of Utah Health to support ARUP’s mission to provide the highest quality diagnostic care.
Park City Anatomic Pathology Update Promises Guidance on Practical Application of Latest WHO Updates
The University of Utah Department of Pathology and ARUP Laboratories will host the 36th Annual Park City Anatomic Pathology Update from February 5–9, 2023.
ARUP President and CSO Tracy George, MD, joined industry leaders and stakeholders at the 13th annual BioHive Summit Thursday to discuss ARUP’s employee focus, staff retention, and company culture.
The near total automation installed in ARUP’s Automated Core Lab increases capacity for testing, provides better turnaround times, reduces risk of human error, and improves staff satisfaction.
ARUP’S new test is the first of its kind to use two distinct biomarkers to identify in utero exposure to kratom, an herbal supplement that may cause neonatal abstinence syndrome.
A $3.6 million gift from the Miller family will enable University of Utah Health and ARUP to expand and refine testing for rare genetic disorders through the Utah NeoSeq Project.
